Skip to content

← All news

Markets

Citizens raises Pharvaris stock price target to $79 on HAE therapy

1 source ·1 article ·Sep 9, 09:00 UTC Haemonetics

Covered by 1 outlet

All coverage · 1 article

Investing.com UK ·Sep 9, 09:00 UTC

Citizens raises Pharvaris stock price target to $79 on HAE therapy